These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11328531)

  • 1. Histologic heterogeneity and mucin phenotypic expression in early gastric cancer.
    Saito A; Shimoda T; Nakanishi Y; Ochiai A; Toda G
    Pathol Int; 2001 Mar; 51(3):165-71. PubMed ID: 11328531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
    Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
    Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma.
    Nakamura T; Yao T; Kabashima A; Nishiyama K; Maehara Y; Tsuneyoshi M
    Histopathology; 2005 Oct; 47(4):357-67. PubMed ID: 16178890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications.
    Lee OJ; Kim HJ; Kim JR; Watanabe H
    Oncol Rep; 2009 Feb; 21(2):387-93. PubMed ID: 19148512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas.
    Kabashima A; Yao T; Maehara Y; Tsuneyoshi M
    Gastric Cancer; 2005; 8(4):220-7. PubMed ID: 16328596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.
    Shiroshita H; Watanabe H; Ajioka Y; Watanabe G; Nishikura K; Kitano S
    Pathol Int; 2004 May; 54(5):311-21. PubMed ID: 15086835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
    Sasaki A; Kitadai Y; Ito M; Tanaka S; Yoshihara M; Haruma K; Chayama K
    Oncology; 2004; 66(5):379-87. PubMed ID: 15331925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of cell cycle-related proteins in gastric intramucosal differentiated-type cancers based on mucin phenotypes: a novel hypothesis of early gastric carcinogenesis based on mucin phenotype.
    Sugai T; Tsukahara M; Endoh M; Shioi Y; Takebe N; Mue Y; Matsushita H; Toyota M; Suzuki K
    BMC Gastroenterol; 2010 Jun; 10():55. PubMed ID: 20525401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions.
    Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
    Oncology; 2001; 61(3):212-20. PubMed ID: 11574777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric mucin phenotype indicates aggressive biological behaviour in early differentiated gastric adenocarcinomas following endoscopic treatment.
    Song K; Yang Q; Yan Y; Yu X; Xu K; Xu J
    Diagn Pathol; 2021 Jul; 16(1):62. PubMed ID: 34256780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
    Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
    Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of gastric gland mucin-specific O-glycan is associated with progression of differentiated-type adenocarcinoma of the stomach.
    Shiratsu K; Higuchi K; Nakayama J
    Cancer Sci; 2014 Jan; 105(1):126-33. PubMed ID: 24138592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
    Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
    Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M
    Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin histochemical analysis of minute gastric differentiated adenocarcinoma.
    Egashira Y; Shimoda T; Ikegami M
    Pathol Int; 1999 Jan; 49(1):55-61. PubMed ID: 10227725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucin histochemistry of the upper gastrointestinal tract.
    Shah M; Shrikhande SS
    Indian J Gastroenterol; 1989 Apr; 8(2):83-4. PubMed ID: 2707846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of mucin, p53 protein and Ki-67 expressions in gastric differentiated-type intramucosal neoplastic lesions obtained from endoscopic mucosal resection samples: a proposal for a new classification of intramucosal neoplastic lesions based on nuclear atypia.
    Sugai T; Inomata M; Uesugi N; Jiao YF; Endoh M; Orii S; Nakamura S
    Pathol Int; 2004 Jun; 54(6):425-35. PubMed ID: 15144402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype.
    Ha Kim G; Am Song G; Youn Park D; Han Lee S; Hyun Lee D; Oh Kim T; Jae Jo H; Heo J; Hwan Kang D; Cho M
    Scand J Gastroenterol; 2006 Aug; 41(8):880-6. PubMed ID: 16803685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
    Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
    Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-evaluation of Phenotypic Expression in Differentiated-type Early Adenocarcinoma of the Stomach.
    Hayakawa M; Nishikura K; Ajioka Y; Aoyagi Y; Terai S
    Pathol Int; 2017 Mar; 67(3):131-140. PubMed ID: 28088838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.